{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T01:38:38Z","timestamp":1778031518002,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004477","name":"Universiteit Stellenbosch","doi-asserted-by":"publisher","award":["Collaborative Capacity Enhancement through Engagement with Districts (SUCCEED)"],"award-info":[{"award-number":["Collaborative Capacity Enhancement through Engagement with Districts (SUCCEED)"]}],"id":[{"id":"10.13039\/501100004477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"publisher","award":["The Positive Action Grant from ViiV Healthcare Limited granted to CC, JL & OVA"],"award-info":[{"award-number":["The Positive Action Grant from ViiV Healthcare Limited granted to CC, JL & OVA"]}],"id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>HIV-associated tuberculosis (TB) is a major cause of death among pregnant women in South Africa. Isoniazid prevention therapy (IPT) strategy was implemented in South Africa concurrently with life-long antiretroviral therapy (ART) to reduce the TB-associated morbidity and mortality in individuals living with HIV. This study assessed the extent of the implementation of IPT and the performance of the Mantoux test by geographic settings of health facilities and residences of pregnant women living with HIV in the Eastern Cape, South Africa.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a data analysis of 1709 pregnant women enrolled in the new electronic database of the prevention of mother-to-child transmission programme of the East London Prospective Cohort Study. Relevant data on place of residence and antenatal care, performance of the Mantoux test and subsequent initiation of IPT were obtained. Descriptive and inferential statistics were employed to analyse the geographical variations and accessibility to Mantoux test and IPT.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The analysis shows that Mantoux test was performed on 803 pregnant women (47%) with significant geographical variation. After controlling for relevant covariates, pregnant women who resided in rural areas (AOR:0.63; CI: 0.47\u20130.84) compared to those who resided in urban areas were significantly less likely to receive Mantoux test. The rate of uptake of IPT was 79% with significant geographic variations. In the unadjusted model, rural place of residence (UOR:0.68; CI: 0.49\u20130.96) was independently associated with lower likelihood of uptake of INH prophylaxis; however, the effect was not significant after controlling for important covariates.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The high uptake rate of isoniazid prevention therapy in pregnant women living with HIV at the study sites is commendable; however, concerted efforts are needed to address the inequality gaps in the roll-out of IPT. Poor performance of Mantoux test is a serious concern and requires the attention of TB programme managers and other relevant authorities.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-019-7769-y","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T20:44:43Z","timestamp":1572468283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Inequality in uptake of isoniazid prevention therapy and Mantoux test among pregnant women with HIV in the Eastern Cape, South Africa"],"prefix":"10.1186","volume":"19","author":[{"given":"Oladele Vincent","family":"Adeniyi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nonkosi","family":"Selanto-Chairman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyitayo Omolara","family":"Owolabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6004-3972","authenticated-orcid":false,"given":"Anthony Idowu","family":"Ajayi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique Kabengele","family":"Kayembe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Ter Goon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avramovic","family":"Gordana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,29]]},"reference":[{"key":"7769_CR1","unstructured":"WHO Department of HIV\/AIDS, Stop TB Department. Guidelines for Intensified Tuberculosis Case-Finding and Isoniazid Preventive Therapy for People Living with HIV in Resource-Constrained Settings. Geneva: WHO; 2010. \n                    http:\/\/www.who.int\/hiv\/pub\/tb\/9789241500708\/en\/\n                    \n                  ."},{"issue":"4","key":"7769_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.4102\/sajhivmed.v13i4.113","volume":"13","author":"CE Martin","year":"2012","unstructured":"Martin CE, Black V. Tuberculosis prevention in HIV-infected pregnant women in South Africa. Southern African Journal of HIV Medicine. 2012;13(4):182\u20134.","journal-title":"Southern African Journal of HIV Medicine"},{"key":"7769_CR3","unstructured":"National Committee on Confidential Enquiries into Maternal Deaths. Saving Mothers 2011-2013: Sixth report on confidential enquiries into maternal deaths in South Africa. Available on: \n                    http:\/\/www.kznhealth.gov.za\/mcwh\/Maternal\/Saving-Mothers-2011-2013-short-report.pdf\n                    \n                  ."},{"key":"7769_CR4","doi-asserted-by":"crossref","unstructured":"Health Systems Trust. District Health Barometer 2013\/14. Durban: HST [taken from ETR.DHIS], 2014.","DOI":"10.12968\/eqhe.2014.1.15.14"},{"issue":"18","key":"7769_CR5","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1097\/QAD.0b013e32834041b7","volume":"24","author":"A Coutsoudis","year":"2010","unstructured":"Coutsoudis A, England K, Rollins N, Coovadia H, Newell M-L, Bland R. Women\u2019s morbidity and mortality in the first 2 years after delivery according to HIV status. AIDS. 2010;24(18):2859\u201366.","journal-title":"AIDS"},{"issue":"1","key":"7769_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/01.qai.0000229015.77569.c7","volume":"43","author":"P Zvandasara","year":"2006","unstructured":"Zvandasara P, Hargrove JW, Ntozini R, Chidawanyika H, Mutasa K, Iliff PJ, et al. Mortality and morbidity among postpartum HIV positive and HIV-negative women in Zimbabwe: risk factors, causes, and impact of single-dose postpartum vitamin a supplementation. J Acquir Immune Defic Syndr. 2006;43(1):107\u201316.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"7769_CR7","doi-asserted-by":"publisher","first-page":"e68733","DOI":"10.1371\/journal.pone.0068733","volume":"8","author":"M Desai","year":"2013","unstructured":"Desai M, Phillips-Howard PA, Odhiambo FO, Katana A, Ouma P, Hamel MJ, et al. An analysis of pregnancy-related mortality in the KEMRI\/CDC health and demographic surveillance system in western Kenya. PLoS One. 2013;8:e68733.","journal-title":"PLoS One"},{"key":"7769_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ijgo.2014.05.024","volume":"127","author":"E Lathrop","year":"2014","unstructured":"Lathrop E, Jamieson DJ, Danel I. HIV and maternal mortality. Int J Gynaecol Obstet. 2014;127:213\u20135.","journal-title":"Int J Gynaecol Obstet"},{"key":"7769_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ijid.2014.12.014","volume":"32","author":"M Bates","year":"2015","unstructured":"Bates M, Ahmed Y, Kapata N, Maeurer M, Mwabab P, Zumla A. Perspectives on tuberculosis in pregnancy. Int J Infect Dis. 2015;32:124\u20137.","journal-title":"Int J Infect Dis"},{"key":"7769_CR10","unstructured":"Gupta A, Gupte N, Patil S, et al. Maternal TB is associated with increased risk of HIV mother-to-child transmission. Conference on Retroviruses and Opportunistic Infections. 2010. Abstract 899. Available from: \n                    http:\/\/retroconference.org\/2010\/Abstracts\/37899.htm\n                    \n                  ."},{"key":"7769_CR11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1471-0528.2010.02504.x","volume":"117","author":"HC Lin","year":"2010","unstructured":"Lin HC, Lin HC, Chen SF. Increased risk of low birthweight and small for gestational age infants among women with tuberculosis. BJOG. 2010;117:585\u201390.","journal-title":"BJOG."},{"key":"7769_CR12","first-page":"59","volume":"8","author":"T Pillay","year":"2004","unstructured":"Pillay T, Sturm AW, Khan M, Adhikari M, Moodley J, Connolly C, et al. Vertical transmission of mycobacterium tuberculosis in KwaZulu Natal: impact of HIV-1 co-infection. Int J Tuberc Lung Dis. 2004;8:59\u201369.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"Suppl 5","key":"7769_CR13","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1097\/01.aids.0000391022.95412.a6","volume":"24","author":"B Durovni","year":"2010","unstructured":"Durovni B, Solange C, Cavalcantea C, Saracenia V, Vellozoa V, Israela G. The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB\/HIV in Rio (THRio). Study AIDS. 2010;24(Suppl 5):S49\u201356.","journal-title":"Study AIDS"},{"key":"7769_CR14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1086\/338641","volume":"34","author":"G Santoro-Lopes","year":"2002","unstructured":"Santoro-Lopes G, de Pinho AM, Harrison LH, Schechter M. Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy. Clin Infect Dis. 2002;34:543\u20136.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"7769_CR15","first-page":"1026","volume":"4","author":"JL Jones","year":"2000","unstructured":"Jones JL, Hanson DL, Dworkin MS, DeCock KM. HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The adult\/adolescent spectrum of HIV disease group. Int T Tuberc Lung Dis. 2000;4(11):1026\u201331.","journal-title":"Int T Tuberc Lung Dis"},{"key":"7769_CR16","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1097\/00002030-200009080-00015","volume":"14","author":"E Girardi","year":"2000","unstructured":"Girardi E, Antonucci G, Vanacore P, Libanore M, Errante I, Matteeli A, et al. Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS. 2000;14:1985\u201391.","journal-title":"AIDS."},{"key":"7769_CR17","unstructured":"World Health Organisation. Global Tuberculosis Report, Geneva. 2017a. Available from: \n                    http:\/\/www.who.int\/tb\/publications\/global_report\/en\/\n                    \n                  ."},{"key":"7769_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12879-016-2109-7","volume":"17","author":"M Semu","year":"2017","unstructured":"Semu M, Fenta TG, Medhin G, Assefa D. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV\/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study. BMC Infect Dis. 2017;17:5.","journal-title":"BMC Infect Dis"},{"key":"7769_CR19","first-page":"CD001363","volume":"2","author":"MJ Smieja","year":"2000","unstructured":"Smieja MJ, Marchetti CA, Cook DJ, Smaill FM. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev. 2000;2:CD001363.","journal-title":"Cochrane Database Syst Rev"},{"key":"7769_CR20","doi-asserted-by":"crossref","unstructured":"Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons 2010. Available from: \n                    http:\/\/www2.cochrane.org\/reviews\/en\/ab000171.html\n                    \n                  .","DOI":"10.1002\/14651858.CD000171.pub3"},{"issue":"7585","key":"7769_CR21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1136\/bmj.39000.486400.55","volume":"334","author":"HJ Zar","year":"2007","unstructured":"Zar HJ, Cotton MF, Strauss S, Karpakis J, Hussey G, Schaaf HS, et al. Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial. BMJ. 2007;334(7585):136.","journal-title":"BMJ."},{"key":"7769_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJMoa1011214","volume":"365","author":"SA Madhi","year":"2011","unstructured":"Madhi SA, Nachman S, Violari A, Kim S, Cotton MF, Bobat R, et al. Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. N Engl J Med. 2011;365:21\u201331.","journal-title":"N Engl J Med"},{"issue":"8","key":"7769_CR23","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.5588\/ijtld.11.0744","volume":"16","author":"CC Bristow","year":"2012","unstructured":"Bristow CC, Larson E, Vilakazi-Nhlapo AK, Wilson M, Klausner JD. Scale-up of isoniazid preventive therapy in PEPFAR-assisted clinical sites in South Africa. Int J Tuberc Lung Dis. 2012;16(8):1020\u20132.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"7769_CR24","doi-asserted-by":"publisher","first-page":"339","DOI":"10.7196\/SAMJ.8290","volume":"104","author":"GJ Churchyard","year":"2014","unstructured":"Churchyard GJ, Chaisson RE, Maartens G, Getahun H. Tuberculosis preventive therapy: an underutilised strategy to reduce individual risk of TB and contribute to TB control. S Afr Med J. 2014;104(5):339\u201343.","journal-title":"S Afr Med J"},{"key":"7769_CR25","unstructured":"Gupta A, Montepiedra G, Aaron L, Theron G, McCarthy K, Onyango-Makumbi C, Chipate T, Masheto G, Shin K, Zimmer B, Sterling TR. Randomized trial of safety of isoniazid preventive therapy during or after pregnancy. In25th Conference on Retroviruses and Opportunistic Infections (CROI 2018) 2018 Mar 4 (pp. 4\u20137)."},{"key":"7769_CR26","first-page":"26","volume-title":"A guide to Monitoring and Evaluation for Collaborative TB\/HIV Activities","author":"World Health Organization","year":"2009","unstructured":"World Health Organization. A guide to Monitoring and Evaluation for Collaborative TB\/HIV Activities. Geneva: WHO; 2009. p. 26\u20137."},{"key":"7769_CR27","unstructured":"World Health Organization. Global tuberculosis control: a short update to the 2010 Report. Geneva, Switzerland 2010."},{"key":"7769_CR28","unstructured":"WHO. TB\/HIV facts: challenges and key issues. Geneva. 2010. Available from: \n                    http:\/\/www.who.int\/hiv\/topics\/tb\/tbhiv_facts_2015\/en\/\n                    \n                  ."},{"issue":"8","key":"7769_CR29","doi-asserted-by":"publisher","first-page":"e104557","DOI":"10.1371\/journal.pone.0104557","volume":"9","author":"KD Yirdaw","year":"2014","unstructured":"Yirdaw KD, Jerene D, Gashu Z, Edginton ME, Kumar AMV, et al. Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia. PLoS One. 2014;9(8):e104557.","journal-title":"PLoS One"},{"key":"7769_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1472-698X-12-2","volume":"12","author":"A Wesen","year":"2012","unstructured":"Wesen A, Mitike G. Provision and awareness for isoniazid preventive therapy among PLHIV in Addis Ababa, Ethiopia. BMC Int Health Hum Rights. 2012;12:2.","journal-title":"BMC Int Health Hum Rights"},{"key":"7769_CR31","unstructured":"Ndebele Nomatter. Time to scale up IPT uptake in South Africa. Spotlight, 2015. Available from: \n                    https:\/\/www.spotlightnsp.co.za\/2015\/10\/22\/time-to-scale-up-ipt-in-south-africa\/\n                    \n                  ."},{"key":"7769_CR32","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1146\/annurev-publhealth-031912-114431","volume":"34","author":"C Dye","year":"2013","unstructured":"Dye C, Glaziou P, Floyd K, Raviglione M. Prospects for tuberculosis elimination. Annu Rev Public Health. 2013;34:271\u201386.","journal-title":"Annu Rev Public Health"},{"key":"7769_CR33","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/s13104-015-1451-y","volume":"8","author":"A Makoni","year":"2015","unstructured":"Makoni A, Chemhuru M, Tshimanga M, Gombe NT, Mungati M, Bangure D. Evaluation of the isoniazid preventive therapy (IPT) program in Shurugwi District, Midlands Province, Zimbabwe, January 2013 to august 2014. BMC Res Notes. 2015;8:476.","journal-title":"BMC Res Notes"},{"issue":"10","key":"7769_CR34","first-page":"S47","volume":"93","author":"EN Omesa","year":"2016","unstructured":"Omesa EN, Kathure IA, Masini E, Mulwa R, Maritim A, Owiti PO, et al. Uptake of isoniazid preventive therapy and its associated factors among HIV positive patients in an urban health Centre, Kenya. East Afr Med J. 2016;93(10):S47\u201354.","journal-title":"East Afr Med J"},{"key":"7769_CR35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.11604\/pamj.2014.17.26.2641","volume":"17","author":"M Mindachew","year":"2014","unstructured":"Mindachew M, Deribew A, Memiah P, Biadgilign S. Perceived barriers to the implementation of isoniazid preventive therapy for people living with HIV in resource constrained settings: a qualitative study. Pan Afr Med J. 2014;17:26.","journal-title":"Pan Afr Med J"},{"issue":"10","key":"7769_CR36","first-page":"775","volume":"7","author":"AMCA Nyamathi","year":"2006","unstructured":"Nyamathi AMCA, Nahid P, Gregerson P, Leake B. A randomized controlled trial of two treatment programs for homeless adults with latent tuberculosis infection. Int J Tuberc Lung Dis. 2006;7(10):775\u201382.","journal-title":"Int J Tuberc Lung Dis"},{"key":"7769_CR37","doi-asserted-by":"crossref","unstructured":"Szakacs TA, Wilson D, Cameron DW, Clark M, Kocheleff P, Muller FJ, et al. Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa. BMC Infect Dis. 2006;13;6:97.","DOI":"10.1186\/1471-2334-6-97"},{"key":"7769_CR38","unstructured":"South African anti-retroviral treatment guidelines. Available from: \n                    http:\/\/www.kznhealth.gov.za\/medicine\/2013_art_guidelines.pdf\n                    \n                  ."},{"issue":"8","key":"7769_CR39","doi-asserted-by":"publisher","first-page":"e0181730","DOI":"10.1371\/journal.pone.0181730","volume":"12","author":"OV Adeniyi","year":"2017","unstructured":"Adeniyi OV, Ajayi AI, Selanto-Chairman N, Goon DT, Boon G, Fuentes YO, et al. Demographic, clinical and behavioural determinants of HIV serostatus non-disclosure to sex partners among HIV-infected pregnant women in eastern cape, South Africa. PLoS One. 2017;12(8):e0181730.","journal-title":"PLoS One"},{"key":"7769_CR40","unstructured":"Statistics South Africa. Census 2001: Investigation into appropriate definitions of urban and rural areas of South Africa; Discussion document. Available from: \n                    http:\/\/www.statssa.gov.za\/census\/census_2001\/urban_rural\/urbanrural.pdf\n                    \n                  ."},{"key":"7769_CR41","volume-title":"Joint Review of HIV, TB and PMTCT Programmes in South Africa","author":"National Department of Health","year":"2014","unstructured":"National Department of Health. Joint Review of HIV, TB and PMTCT Programmes in South Africa. Pretoria: Department of Health; 2014."},{"key":"7769_CR42","unstructured":"World Health Organisation. Factsheet on Tuberculosis. Available from: \n                    http:\/\/www.who.int\/mediacentre\/factsheets\/fs104\/en\/\n                    \n                  ."},{"issue":"1","key":"7769_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4102\/phcfm.v7i1.767","volume":"7","author":"OV Adeniyi","year":"2015","unstructured":"Adeniyi OV, Yogeswaran P, Wright G, Longo-Mbenza B. Diabetic patients\u2019 perspectives on the challenges of glycaemic control. African journal of primary health care & family medicine. 2015;7(1):1\u20138.","journal-title":"African journal of primary health care & family medicine"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-7769-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-019-7769-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-7769-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:24:32Z","timestamp":1603844672000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-019-7769-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,29]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["7769"],"URL":"https:\/\/doi.org\/10.1186\/s12889-019-7769-y","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,29]]},"assertion":[{"value":"3 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Walter Sisulu University Ethics Committee approved the study. Participants gave written consent, and the study was conducted by respecting the right of participants to privacy, anonymity and confidentiality. Also, we obtained parental\/legal consent for participants under 18\u2009years old.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AIA is an associate editor at BMC Public Health. Other authors declared that they had no conflict of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1407"}}